Cargando…
Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis
BACKGROUND/AIMS: Limited treatment options are available for patients with hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Transarterial radioembolization using Yttrium-90 microspheres is a new treatment modality for HCC with PVT. For this analysis, we compared responses to treatme...
Autores principales: | Cho, Young Youn, Lee, Minjong, Kim, Hyo-Cheol, Chung, Jin Wook, Kim, Yun Hwan, Gwak, Geum-Youn, Bae, Si Hyun, Kim, Do Young, Heo, Jeong, Kim, Yoon Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858257/ https://www.ncbi.nlm.nih.gov/pubmed/27149067 http://dx.doi.org/10.1371/journal.pone.0154986 |
Ejemplares similares
-
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
por: Hur, Moon Haeng, et al.
Publicado: (2023) -
Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021) -
Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
por: Kim, Pyeong Hwa, et al.
Publicado: (2019) -
CT Findings of Completely Regressed Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis after Transcatheter Arterial Chemoembolization
por: Yoon, Jeong-Hee, et al.
Publicado: (2010) -
Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: The impact of portal vein thrombosis on survival
por: Somma, Francesco, et al.
Publicado: (2019)